ArticleTheranostics2026
3D vascular mapping reveals multi-organ injury following severe acute pancreatitis.
Article in Theranostics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale: Severe acute pancreatitis (SAP) is a life-threatening disease with substantial mortality, primarily resulting from pancreatic microcirculatory failure that initiates multiple organ dysfunction syndrome (MODS). While early microvascular injury is widely recognized as a critical determinant of disease progression, the precise spatiotemporal dynamics and mechanisms underlying vascular damage remain largely elusive, limiting the development of effective therapeutic interventions. Methods: An integrated imaging method that combines vascular labeling, tissue clearing, and light-sheet microscopy is proposed to realize 3D mapping and quantitative analysis of multi-organ vascular networks in a mouse model of SAP. Results: We found that SAP induced systemic microvascular disruption accompanied by organ-specific perfusion deficits across multiple vital organs. As the primary site of injury, the pancreas exhibited the earliest and most severe hypoperfusion, whereas remote organs showed a delayed decline in perfusion, with different trends among organs. Specifically, perfusion in the lung, heart, and kidney decreased gradually with disease progression, perfusion in the liver and spleen remained stable within the first 6 hours and then decreased rapidly, while the brain perfusion showed a sharp decrease at the end stage. These distinct perfusion trajectories are consistent with sequential compensatory and decompensatory responses. More importantly, the administration of heparin sodium within 12 hours after SAP induction significantly improved survival, reversed multi-organ hypoperfusion, and preserved microvascular integrity across affected organs. Conclusions: This study identifies systemic vascular injury as a key driver of multiple organ dysfunction in SAP and provides a convincing evidence that early intervention with heparin sodium can improve multi-organ hypoperfusion, preserve microvascular integrity, and enhance survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.